Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
Author(s) -
Douglas S. Lee
Publication year - 2005
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.294.10.1240
Subject(s) - medicine , heart failure , ejection fraction , pharmacotherapy , ace inhibitor , population , angiotensin converting enzyme , cardiology , blood pressure , environmental health
Patients with heart failure have a wide spectrum of mortality risks. To maximize the benefit of available pharmacotherapies, patients with high mortality risk should receive high rates of drug therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom